• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用质量改进方法,通过呼吸治疗师主导的途径缩短哮喘患者的住院时间。

Using Quality Improvement Methods to Reduce Length of Stay with a Respiratory Therapist-driven Pathway for Asthma.

作者信息

Tang Katherine M, Mills Cloyde, McCann Teresa A, Rosenthal Susan L, Lee Jennifer

机构信息

From the Department of Pediatrics, Columbia University College of Physicians and Surgeons, New York, N.Y.

NewYork-Presbyterian/Morgan Stanley Children's Hospital, New York, N.Y.

出版信息

Pediatr Qual Saf. 2025 Jun 5;10(3):e817. doi: 10.1097/pq9.0000000000000817. eCollection 2025 May-Jun.

DOI:10.1097/pq9.0000000000000817
PMID:40475830
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12140678/
Abstract

INTRODUCTION

Asthma pathways reduce hospital length of stay (LOS), and respiratory therapists (RTs) can optimize care. This study aimed to use quality improvement methods to implement an asthma-specific RT role and RT-driven asthma pathway. The SMART aim was to reduce LOS for pediatric patients admitted for asthma to the general inpatient units by 20% within 22 months.

METHODS

We included children 2-17 years of age who were admitted to a general inpatient unit for asthma. We excluded patients transferred from another hospital, initially admitted to the pediatric intensive care unit, or with comorbidities predisposed to severe respiratory illnesses. We used the Model for Improvement to design and study interventions. Key drivers focused on standardizing care, leveraging provider expertise, and supporting providers with education and technology. The outcome measure was LOS. The main process measure was the early transition to an albuterol metered-dose inhaler. Balancing measures were hospital reutilization rates and escalation of care. We used statistical process control charts and run charts to analyze the data.

RESULTS

The study included 743 patients, with 339 in the intervention period. The intervention group had a younger median age (4 [3, 7] versus 6 [3, 10] years, < 0.001) and more publicly insured patients (84% versus 68%, < 0.001). LOS decreased from 39.4 to 30.7 hours, achieving our SMART aim without adversely affecting the balancing measures.

CONCLUSIONS

Quality improvement methodology aids in implementing an RT-driven asthma pathway on the pediatric floors to decrease LOS without adversely influencing hospital reutilization rates or transfers for escalation of care.

摘要

引言

哮喘治疗路径可缩短住院时长,呼吸治疗师(RT)能够优化护理。本研究旨在运用质量改进方法来实施特定于哮喘的RT角色及由RT驱动的哮喘治疗路径。具体目标是在22个月内将入住普通住院病房的哮喘儿科患者的住院时长缩短20%。

方法

我们纳入了2至17岁入住普通住院病房治疗哮喘的儿童。排除了从其他医院转来的患者、最初入住儿科重症监护病房的患者或患有易导致严重呼吸道疾病合并症的患者。我们使用改进模型来设计和研究干预措施。关键驱动因素集中在规范护理、利用提供者的专业知识以及通过教育和技术支持提供者。结果指标是住院时长。主要过程指标是尽早过渡到使用沙丁胺醇定量气雾剂。平衡指标是医院再利用率和护理升级情况。我们使用统计过程控制图和运行图来分析数据。

结果

该研究纳入了743名患者,其中339名在干预期。干预组的中位年龄更小(4[3,7]岁对6[3,10]岁,<0.001),且公共保险患者更多(84%对68%,<0.001)。住院时长从39.4小时降至30.7小时,实现了我们的具体目标,且未对平衡指标产生不利影响。

结论

质量改进方法有助于在儿科病房实施由RT驱动的哮喘治疗路径,以缩短住院时长,同时不会对医院再利用率或因护理升级而进行的转院产生不利影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/b3e312379af9/pqs-10-e817-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/10fd5524f1b5/pqs-10-e817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/ff2f0647aa5a/pqs-10-e817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/74df6d4252a3/pqs-10-e817-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/32474e7a415d/pqs-10-e817-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/b3e312379af9/pqs-10-e817-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/10fd5524f1b5/pqs-10-e817-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/ff2f0647aa5a/pqs-10-e817-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/74df6d4252a3/pqs-10-e817-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/32474e7a415d/pqs-10-e817-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b5c7/12140678/b3e312379af9/pqs-10-e817-g005.jpg

相似文献

1
Using Quality Improvement Methods to Reduce Length of Stay with a Respiratory Therapist-driven Pathway for Asthma.运用质量改进方法,通过呼吸治疗师主导的途径缩短哮喘患者的住院时间。
Pediatr Qual Saf. 2025 Jun 5;10(3):e817. doi: 10.1097/pq9.0000000000000817. eCollection 2025 May-Jun.
2
A Respiratory Therapist-Driven Asthma Pathway Reduced Hospital Length of Stay in the Pediatric Intensive Care Unit.呼吸治疗师主导的哮喘路径可缩短儿科重症监护病房的住院时间。
Respir Care. 2019 Nov;64(11):1325-1332. doi: 10.4187/respcare.06626. Epub 2019 May 14.
3
Outcomes of a respiratory therapist driven high flow nasal cannula management protocol for pediatric critical asthma patients.由呼吸治疗师主导的针对小儿重症哮喘患者的高流量鼻导管管理方案的效果。
Pediatr Pulmonol. 2023 Oct;58(10):2881-2888. doi: 10.1002/ppul.26606. Epub 2023 Aug 22.
4
Standardized Asthma Admission Criteria Reduce Length of Stay in a Pediatric Emergency Department.标准化哮喘入院标准可缩短儿科急诊科的住院时间。
Acad Emerg Med. 2016 Mar;23(3):289-96. doi: 10.1111/acem.12890. Epub 2016 Feb 13.
5
Implementing a Respiratory Therapist-Driven Continuous Albuterol Weaning Protocol in the Pediatric ICU.在儿科 ICU 中实施呼吸治疗师主导的持续沙丁胺醇撤药方案。
Respir Care. 2019 Nov;64(11):1358-1365. doi: 10.4187/respcare.06447. Epub 2019 Mar 19.
6
Improving efficiency of pediatric emergency asthma treatment by using metered dose inhaler.使用定量吸入器提高小儿急诊哮喘治疗的效率。
J Asthma. 2019 Oct;56(10):1079-1086. doi: 10.1080/02770903.2018.1514629. Epub 2018 Sep 12.
7
Effects of a PICU Status Asthmaticus De-Escalation Pathway on Length of Stay and Albuterol Use.儿科危重症哮喘降阶梯治疗路径对住院时间和沙丁胺醇使用的影响。
Pediatr Crit Care Med. 2018 Jul;19(7):658-664. doi: 10.1097/PCC.0000000000001551.
8
Improving Inpatient Asthma Management: The Implementation and Evaluation of a Pediatric Asthma Clinical Pathway.改善住院哮喘管理:儿科哮喘临床路径的实施与评估
Pediatr Qual Saf. 2017 Aug 22;2(5):e041. doi: 10.1097/pq9.0000000000000041. eCollection 2017 Sep-Oct.
9
Safe and Effective Use of Score-Based Continuous Albuterol Therapy in a Pathway for Treatment of Pediatric Asthma Exacerbation.基于评分的持续沙丁胺醇治疗在儿科哮喘加重治疗途径中的安全有效使用。
Respir Care. 2022 Nov;67(11):1396-1404. doi: 10.4187/respcare.10083. Epub 2022 Aug 9.
10
Decreasing ICU and Hospital Length of Stay through a Standardized Respiratory Therapist-driven Electronic Clinical Care Pathway for Status Asthmaticus.通过标准化的、由呼吸治疗师主导的电子临床护理路径缩短哮喘持续状态患者在重症监护病房(ICU)和医院的住院时间
Pediatr Qual Saf. 2023 Dec 5;8(6):e697. doi: 10.1097/pq9.0000000000000697. eCollection 2023 Nov-Dec.

引用本文的文献

1
Improving the management of acute asthma in children through an integrated care pathway: an implementation study protocol.通过综合护理路径改善儿童急性哮喘管理:一项实施研究方案
Front Pediatr. 2025 Aug 19;13:1646499. doi: 10.3389/fped.2025.1646499. eCollection 2025.

本文引用的文献

1
Implementation of a Respiratory Therapist-Driven Protocol for Spirometry and Asthma Education in a Pediatric Out-Patient Primary Care Setting.在儿科门诊初级保健环境中实施呼吸治疗师主导的肺量计和哮喘教育方案。
Respir Care. 2023 Sep;68(9):1195-1201. doi: 10.4187/respcare.10930. Epub 2023 May 16.
2
Sustaining Long-Term Asthma Outcomes at a Community and Tertiary Care Pediatric Hospital.维持社区和三级儿科医院的长期哮喘结局。
Hosp Pediatr. 2023 Feb 1;13(2):130-138. doi: 10.1542/hpeds.2021-006224.
3
Impact of a National Quality Collaborative on Pediatric Asthma Care Quality by Insurance Status.
国家质量合作对保险状况下儿科哮喘护理质量的影响。
Acad Pediatr. 2021 Aug;21(6):1018-1024. doi: 10.1016/j.acap.2021.02.009. Epub 2021 Feb 17.
4
Improving Disposition Decision-Making for Pediatric Diabetic Ketoacidosis: A Quality Improvement Study.改善儿童糖尿病酮症酸中毒的处置决策:一项质量改进研究。
Pediatr Qual Saf. 2020 Feb 15;5(2):e260. doi: 10.1097/pq9.0000000000000260. eCollection 2020 Mar-Apr.
5
Pathways for Improving Inpatient Pediatric Asthma Care (PIPA): A Multicenter, National Study.改善住院儿科哮喘护理途径(PIPA):一项多中心、全国性研究。
Pediatrics. 2020 Jun;145(6). doi: 10.1542/peds.2019-3026. Epub 2020 May 6.
6
A Respiratory Therapist-Driven Pathway Improves Timeliness of Extubation Readiness Assessment in a Single PICU.呼吸治疗师主导的路径可改善单个儿科重症监护病房中拔管准备评估的及时性。
Pediatr Crit Care Med. 2020 Aug;21(8):e513-e521. doi: 10.1097/PCC.0000000000002326.
7
Implementing pediatric inpatient asthma pathways.实施儿科住院哮喘路径。
J Asthma. 2021 Jul;58(7):893-902. doi: 10.1080/02770903.2020.1741612. Epub 2020 Mar 18.
8
A Respiratory Therapist-Driven Asthma Pathway Reduced Hospital Length of Stay in the Pediatric Intensive Care Unit.呼吸治疗师主导的哮喘路径可缩短儿科重症监护病房的住院时间。
Respir Care. 2019 Nov;64(11):1325-1332. doi: 10.4187/respcare.06626. Epub 2019 May 14.
9
Implementing a Respiratory Therapist-Driven Continuous Albuterol Weaning Protocol in the Pediatric ICU.在儿科 ICU 中实施呼吸治疗师主导的持续沙丁胺醇撤药方案。
Respir Care. 2019 Nov;64(11):1358-1365. doi: 10.4187/respcare.06447. Epub 2019 Mar 19.
10
The Economic Burden of Pediatric Asthma in the United States: Literature Review of Current Evidence.美国儿科哮喘的经济负担:现有证据的文献综述。
Pharmacoeconomics. 2019 Feb;37(2):155-167. doi: 10.1007/s40273-018-0726-2.